LSD micro-dosing trials planned for late-stage cancer patients
July 15 2021 – Team MindFuel
Auckland scientists would like to dose advanced-stage cancer patients with mico-doses of the psychedelic drug LSD.
Lead researcher, Lisa Reynolds, a health psychologist from Auckland University, explained to First Up that LSD could offer the patients a cognitive pathway to reduce anxiety around dying and allow them to connect with what was important to them.
She says "The research I've seen so far suggests that psychedelics such as LSD might have the potential to improve quality of life, reduce fear of death, reduce anxiety and depression, increase spirituality. There's a whole lot of early-stage findings that are pretty compelling."
The self-dosing of the LSD at one tenth of the normal dosage by participants in the trial every 3 days would be legal. But the research team are still waiting on approval for the trial.
Sources: RNZ.
Lead researcher, Lisa Reynolds, a health psychologist from Auckland University, explained to First Up that LSD could offer the patients a cognitive pathway to reduce anxiety around dying and allow them to connect with what was important to them.
She says "The research I've seen so far suggests that psychedelics such as LSD might have the potential to improve quality of life, reduce fear of death, reduce anxiety and depression, increase spirituality. There's a whole lot of early-stage findings that are pretty compelling."
The self-dosing of the LSD at one tenth of the normal dosage by participants in the trial every 3 days would be legal. But the research team are still waiting on approval for the trial.
Sources: RNZ.
0 comments